Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
about
Murine Models of Splenic Marginal Zone Lymphoma: A Role for Cav1?Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphomaMDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.Molecular characterization of the region 7q22.1 in splenic marginal zone lymphomas.Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma.Exon 1 disruption alters tissue-specific expression of mouse p53 and results in selective development of B cell lymphomasEmployment of oligodeoxynucleotide plus interleukin-2 improves cytogenetic analysis in splenic marginal zone lymphoma.Genomic profiles of MALT lymphomas: variability across anatomical sites.DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features.Genetics and Prognostication in Splenic Marginal Zone Lymphoma: Revelations from Deep Sequencing.Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development.Whole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.Marginal zone lymphoma: old, new, targeted, and epigenetic therapies.Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement.Whole genome profiling and other high throughput technologies in lymphoid neoplasms--current contributions and future hopes.Treatment of splenic marginal zone lymphoma: should splenectomy be abandoned?Splenic marginal zone lymphoma: disease features and management.B-cell lymphoma mutations: improving diagnostics and enabling targeted therapies.Splenic marginal-zone lymphoma: ontogeny and genetics.Tissue proteomics of splenic marginal zone lymphoma.Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.Genetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.Early stages in the ontogeny of small B-cell lymphomas: genetics and microenvironment.t(11;14)(q23;q32) involving IGH and DDX6 in nodal marginal zone lymphoma.High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.Treatment of splenic marginal zone lymphoma of the CNS with high-dose therapy and allogeneic stem cell transplantationThe prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma.Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database.Comparative outcomes of rituximab-based systemic therapy and splenectomy in splenic marginal zone lymphoma.Karyotyping of diffuse large B-cell lymphomas: loss of 17p is associated with poor patient outcome.Splenic marginal zone lymphoma with villous lymphocytes in patients with human immunodeficiency virus.Distinct clinical characteristics draw a new prognostic model for splenic marginal zone lymphoma in HBV high prevalent region.Unusual Course of Splenic Marginal Zone Lymphoma.
P2860
Q28070123-C3B422E9-4BC9-4F77-AC42-FE2A56169F15Q28537689-48333DD1-150B-47D3-A17A-6C70D7CBA736Q33869257-E1C6014F-1F55-49D8-96CB-A15C13125314Q34034713-B39C706C-272C-4AC6-A988-F7CBF7B5FD2AQ34252178-6065C9F1-9C20-4E50-84D2-D32793B3C409Q34293927-0DECB9F3-5DEC-4C32-A98C-EAB95ABB8A89Q34482189-2E6CD016-93D3-4B08-B8CC-59ECE546F5DCQ35001307-7D809C89-E482-487C-A2F2-B109A4A7DC09Q35082540-ACF11B5F-D42A-4355-BC3B-2E3B378A4912Q35561291-15EC2CE1-4739-4F95-B228-9FA863231863Q35812737-C9DE592D-3F40-4E3B-871B-FFA78153A8E8Q35824945-57E1E93E-13DB-4FE9-9A4C-4945CF3E7128Q35926049-342F5595-BBA3-4BBD-8863-FF3CB78D48F8Q36193517-FC104101-4FEE-4182-BC33-0FC3E9A3F56AQ36203511-9417E8E3-B387-4B3A-A37B-B5617CF144A7Q36630461-E3D9BBDA-966C-4F54-9D7A-927B71242AA3Q36768594-F8B1A57E-C159-44AB-92D7-32BCEE804CCBQ36862542-DB2565EE-4E6B-4B8A-A451-1E04EAEB27F8Q37365459-471328DA-1FC8-4753-B8B4-0932F85C569DQ38071077-773F47F9-AE48-4355-92CD-E6BF4DF711D6Q38139569-58F77A94-B149-46E8-9E20-2071F317C2BBQ38156238-4AF93E05-5E24-44F3-BC18-25F193D61B67Q38185363-2C7D315E-A7DB-4000-92DD-D892E406AF18Q38209575-7676F184-7518-43F8-B61A-216B73440667Q38413335-632C1508-DD29-47CD-91E3-333F0FA1CC0EQ38798801-4E0EE9B8-F9D5-4B93-B078-E16829BD538AQ38819164-FDA15BF0-EFF3-47BF-8009-9E4B28A80387Q39230986-D2F07D3F-9A0C-4B1E-89D7-36022718E3AEQ39281671-4690C749-76DD-4FA2-88E0-B41D1BC3EAFAQ39311207-9AF9E8A9-CF88-404F-B7C1-A659D6B9592DQ39347902-834BCC00-FC69-464D-AEE4-AF6ACBE37178Q42390771-D40AE69D-BBC0-421F-9678-17E406EE7A54Q43854217-ADBDBCEF-3CDF-48DE-BC2B-1F4402762E94Q44133528-3540F159-194A-4A94-ACD8-284E8478B2A8Q44223923-96796E94-1886-4202-8292-6A63289920FEQ44628624-09D68BEE-9643-4BE1-8CD0-A021CFE474A0Q45349447-6223AA82-F1F8-4715-9B73-27F575BF6454Q45357289-715FEADB-0DA5-4FCB-AD76-62B0429ACFEBQ47123855-F99266F0-5986-4012-90A1-0831F0117B5EQ47153921-3EC6F6FF-86BF-4FB6-947B-F5CDA12F25BB
P2860
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@en
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@nl
type
label
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@en
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@nl
prefLabel
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@en
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group.
@nl
P2093
P50
P1433
P1476
Cytogenetic aberrations and th ...... Splenic B-Cell Lymphoma Group
@en
P2093
Alexandra Traverse-Glehen
Ana Ferrer
Anastasia Athanasiadou
Anne Gardiner
Blanca Espinet
Catherine Thieblemont
Cristina Baró
David Oscier
Elisa Luño
Estela Matutes
P304
P356
10.1182/BLOOD-2010-02-267476
P407
P577
2010-05-17T00:00:00Z